Tag: #Global Trends

Key Development Global biopharmaceutical leader Amgen has initiated a voluntary nationwide recall encompassing at least 944,142 bottles of its chronic... Read more

Key Development Global specialized biopharmaceutical leader Swedish Orphan Biovitrum AB (Sobi) has officially announced the receipt of a Complete Response... Read more

Key Development The U.S. Department of Justice (DOJ) has officially closed its multi-year criminal investigation into healthcare giant Abbott Laboratories... Read more

Key Development The European Medicines Agency (EMA) has formally issued a negative regulatory recommendation, calling for the revocation of the... Read more

Key Development China's National Healthcare Security Administration (NHSA) has officially released its updated regulatory ledger showing that next-generation GLP-1 receptor... Read more

Key Development Global biopharmaceutical powerhouse AbbVie (NYSE: ABBV) has officially secured U.S. Food and Drug Administration (FDA) approval expanding the... Read more

Key Development Indian pharmaceutical manufacturer Alembic Pharmaceuticals Ltd has secured final regulatory approval from the US Food and Drug Administration... Read more

Key Development German pharmaceutical major Boehringer Ingelheim has finalized a comprehensive multi-project research collaboration with biotech innovator Immunai to identify... Read more

Key Development The global consumer health landscape witnessed a major strategic consolidation play as Haleon, the multi-billion-dollar manufacturer of Centrum... Read more